Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exubera versus Lantus in poorly controlled type 2 diabetes on multiple oral agents
2006-004421-28Phase 4Completed
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Exubera arm with Lantus arm (2 arms). Primary endpoint: Change in HbA1c at week 26. Started Oct 2006; status: completed.
02
Drugs
Technosphere insulininsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-004421-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004421-28.